Upgrade to SI Premium - Free Trial

Vaxcyte, Inc. (PCVX) Tops Q3 EPS by 27c

November 5, 2024 4:50 PM

Vaxcyte, Inc. (NASDAQ: PCVX) reported Q3 EPS of ($0.83), $0.27 better than the analyst estimate of ($1.10).

For earnings history and earnings-related data on Vaxcyte, Inc. (PCVX) click here.

Categories

Earnings

Next Articles